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Objective: The visceral sensitivity index (VSI) is a useful self-report measure of the gastrointestinal symptom-specific
anxiety (GSA) of patients with irritable bowel syndrome (IBS). Previous research has shown that worsening GSA in
IBS patients is related to the severity of GI symptoms, suggesting that GSA is an important endpoint for
intervention. However, there is currently no Japanese version of the VSI. We therefore translated the VSI into
Japanese (VSI-J) and verified its reliability and validity.
Material and methods: Participants were 349 university students aged 18 and 19 years and recruited from an
academic class. We analyzed data from the VSI-J, Anxiety Sensitivity Index (ASI), Hospital Anxiety and Depression
scale (HAD), and Irritable Bowel Syndrome Severity Index (IBS-SI). The internal consistency, stability, and factor
structure of the VSI-J and its associations with anxiety, depression and severity measures were investigated.
Results: The factor structure of the VSI-J is unidimensional and similar to that of the original VSI (Cronbach’s
α = 0.93). Construct validity was demonstrated by significant correlations with ASI (r = 0.43, p < 0.0001), HAD-ANX
(r = 0.19, p = 0.0003), and IBS-SI scores (r = 0.45, p < 0.0001). Furthermore, the VSI-J was a significant predictor of
severity scores on the IBS-SI and demonstrated good discriminant (p < 0.0001) and incremental (p < 0.0001) validity.
Conclusion: These findings suggest that the VSI-J is a reliable and valid measure of visceral sensitivity.
Keywords: Gastrointestinal-specific anxiety, Irritable Bowel Syndrome (IBS), Motility, Psychosomatics, Validation,
Visceral Sensitivity Index (VSI)Introduction
Irritable bowel syndrome (IBS) is a functional gastrointes-
tinal disorder not associated with organic disease that con-
sists of chronic abdominal discomfort associated with
abnormal bowel habits [1,2]. The prevalence of IBS has
been reported at approximately 5–11% in industrialized
countries [3]. Patients with IBS have been shown to have
poor health-related quality of life (QOL) when compared
with healthy individuals [4] and often experience a signifi-
cant financial burden—indeed, their economic impact* Correspondence: sfukudo@med.tohoku.ac.jp
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unless otherwise stated.factor increases from 1.1 to 6.0 when compared with
non-IBS individuals [5]. The characteristic pathophysio-
logical features of IBS are dysmotility [6,7], visceral
sensitivity [8,9], and psychological disturbances [10,11].
The GI symptoms of IBS may aggravate depression and
anxiety and be associated with psychosocial stress; in-
deed, patients with IBS symptoms improve with recov-
ery from psychological disturbances [12-14]. At least
two studies have shown that patients with IBS report a
high frequency of comorbid anxiety disorders such as
panic disorder, agoraphobia, generalized anxiety disorder,
and post-traumatic stress disorder [14,15].
Anxiety symptoms play a major role in the onset of IBS
and in the maintenance and aggravation of GI symptomstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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GI symptoms and pain is related to brain function through
the emotional motor system (EMS) and responses of the
neuroendocrine and autonomic nervous systems [16]. For
example, in studies that used colonic barostats, the thal-
amus, insular cortex, anterior cingulate gyrus, and pre-
frontal cortex were activated; these activations were
associated with abdominal pain and psychological ab-
normalities such as anxiety and depression [12,17-19].
Patients with IBS show greater activation of the pre-
frontal cortex and anterior cingulate gyrus than do
healthy individuals, and also perceive more abdominal
pain [12,16-18]. Patients with IBS also demonstrate en-
hanced pathological vigilance and selective attention for
their GI symptoms [20,21]. Thus, the association of
brain function with pathological vigilance and selective
attention for GI symptoms suggests a neurophysiological
foundation for visceral sensitivity [22-24]. GI symptoms
are not only external stressors but also act as internal
stressors by causing and aggravating anxiety (gastrointes-
tinal-specific anxiety: GSA) [25]. Excessive activity of the
amygdala can activate the insular cortex [26], prefrontal
cortex, and the anterior cingulate gyrus, which ultimately
may lead to GSA and aggravated GI symptoms [4,27]. In-
terventions aimed at reducing GSA associated with IBS
should therefore contribute to an improvement in the
QOL of patients with IBS [27,28].
GSA is defined as “the cognitive, affective, and behav-
ioral response stemming from fear of GI sensations,
symptoms, and the context in which these visceral sen-
sations and symptoms occur” (28, p.89). For example,
the fear of visceral sensations and GI symptoms is re-
lated to situations involving restaurants, parties, or first-
time visits to locations where bathroom facilities are un-
known or difficult to reach; such experiences may cause
particular cognitive or behavioral responses. IBS patients
may engage in avoidance behaviors that cause GSA,
increase vigilance or attention to visceral sensations, and
show excessive reactions to low-level visceral sensation
[29]. Labus et al. [27] have developed the Visceral Sensi-
tivity Index (VSI) to assess specific GSA seen in patients
with IBS.
The validity and reliability of the VSI have been con-
firmed in several studies (27 28, 30). In studies with both
university students and IBS patients, the VSI has been
shown to have a unidimensional factor structure [27,28].
A high level of internal consistency has been demonstrated
in a combined group of younger healthy participants, IBS
patients (Cronbach’s α ranging from 0.90 to 0.92), and
adults with IBS (Cronbach’s α = 0.93) [27,28]. Test-retest
reliability estimates showed that, four weeks after testing,
the inter-class coefficient was 0.86 [30]. Further, the con-
struct validity has been extensively studied; results for the
original VSI show moderate to strong positive correlationswith measures of anxiety sensitivity (AS), state anxiety, and
severity of GI symptoms [27,28,30]. The original VSI also
showed a strong positive correlation with the depressive
symptoms of IBS patients, but there was no significant
correlation with the depressive symptoms of university
students with IBS [28]. In addition, the Norwegian ver-
sion of the VSI showed no correlation with the depres-
sive symptoms or indicators of food sensitivity of IBS
patients [30].
There is currently no Japanese version of the VSI; how-
ever, there is a clear need for such an instrument because
it could be useful for verifying treatment effects in IBS pa-
tients and may therefore be indispensable for the future
development of IBS treatments [27]. In the present study,
we report our newly developed Japanese version of the
VSI and test its validity and reliability. Reliability and val-
idity have been confirmed in a previous analog study of
university students [28]. As a large sample was necessary
to develop the Japanese version of the VSI, the present
study was conducted with a sample of university students,
including those with symptoms of IBS. We then tested the
following hypotheses.
1. The Japanese version of the VSI will exhibit a
unidimensional factor structure.
2. The Japanese version of the VSI will show moderate
positive correlations with measures of AS, state
anxiety, and the severity of IBS symptoms;
furthermore, it will show weak positive correlations
with measures of depressive symptoms.
3. The Japanese version of the VSI will predict the




We recruited 875 undergraduate student participants
from Nagasaki University in Japan; Figure 1 shows the
selection process. For the present study, we were inter-
ested in younger participants (less than 20 years old).
After screening for age, the data of 349 students (male =
207, female = 142, mean age = 19 years) was available for
analysis. The participants answered all items on the VSI
questionnaire.
Japanese Version of the Visceral Sensitivity Index (VSI-J)
The VSI was translated into Japanese using a standardized
procedure. Two researchers, one a clinical psychologist
knowledgeable in psychosomatic medicine, translated the
original version. A medical doctor who specializes in psy-
chosomatic medicine then confirmed the consistency of
the translated Japanese version. A bilingual researcher
(native English speaker) back-translated the Japanese VSI
into English. The VSI-J was established after comparing
Potential participants assessed
for eligibility ( n = 875 ) 
Attended class
( n = 819 ) 
Consented to 
participate
( n =409 )
Eligible ( n = 349 ) 
Absent from  class
( n  = 66 ) 
Did not respond to the 
Questionnaire ( n = 410 ) 
Excluded ( n = 60 ) 
Did not complete the 
questionnaire ( n = 38 )







Figure 1 Flow chart showing the selection of the participants.
Of 875 possible participants, 66 were absent from class, 410 did not
respond to the questionnaire, 38 did not fully complete the
questionnaire, and 22 were excluded because they were 20 years of
age or older. We analyzed the data of the remaining 349 persons
who answered all of the items on the questionnaire.
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there was agreement among the researchers about the nu-
ances (Tables 1 and 2).
The VSI measures gastrointestinal specific anxiety using
15 questionnaire items, with responses ranging from 1
(strongly agree) to 6 (strongly disagree). The VSI was “reverse
scored” according to previously established methods [27],
with scores ranging from 0 to 5. Total scores ranged from 0
(no GI-specific anxiety) to 75 (severe GI-specific anxiety).Rome III diagnostic questionnaire
Rome III criteria are widely used for the diagnosis of
IBS. These criteria include recurrent abdominal pain or
discomfort (on at least 3 days/month in the last 3 months)
associated with two or more of the following: [1] im-
proved by defecation, [2] onset associated with a change
in frequency of stool, and [3] onset associated with a
change in form (appearance) of stool. The Rome III diag-
nostic questionnaire has been confirmed as a reliable and
valid self-administered questionnaire for the purpose of
diagnosing IBS (Drs. Kanazawa & Fukudo, personal com-
munication). The questionnaire determines whether a per-
son is IBS-positive or non-IBS.
The IBS Severity Index (IBS-SI)
In the present study, the IBS-SI was used to assess the
severity of GI symptoms [31]. The IBS-SI consists of five
items with total scores ranging from 0 to 500. Mild, mod-
erate and severe symptoms of IBS are indicated by scores
of 75 to 174, 175 to 299, and 300 or over, respectively [31].
The VSI has shown strong positive correlations with the
severity of the GI symptoms of both healthy (non-IBS)
individuals and individuals with IBS (IBS-positive) [28].
Therefore, the IBS-SI measure of symptom severity was
used to examine the construct validity of the VSI-J.
The Hospital Anxiety and Depression scale (HAD)
The HAD is a 14-item self-administered anxiety and
depression scale specifically designed for use in non-
psychiatric settings [32]. Seven of the items relate to
anxiety (HAD-ANX) and seven to depression (HAD-
DEP). Participants rate each item on a scale from 0 to 3.
Higher ratings indicate a greater number of symptoms
of anxiety or depression. Two scores (one each for the
HAD-ANX and the HAD-DEP) are calculated, each
ranging from 0 to 21. Scores of 0 to 7 on the respective
subscales are considered normal, with 8 to 10 being bor-
derline and scores of 11 to 21 indicating probable clinical
cases [32]. Our scoring methods conformed to those of
the original version of the scale [32]. Scores on the original
VSI were significantly and moderately correlated with
scores on the HAD-ANX but showed a weak correlation
with HAD-DEP scores [28]. Therefore, the HAD was used
to examine the construct validity of the VSI-J.
The Anxiety Sensitivity Index (ASI)
The ASI is a 16-item self-administered questionnaire about
anxiety sensitivity designed to assess fear of bodily sensa-
tions associated with arousal [33,34]. Items are rated on
5-point Likert scales ranging from 0 (very little) to 4 (very
much). Previous research has shown that the original VSI
is significantly and strongly correlated with measures of AS
among both IBS patients and healthy individuals [28]. AS
was related to an understanding of GSA constructed
Table 1 Original version of the VSI [27]













1 I worry that whenever I eat during the day, bloating and distension in
my belly will get worse.
1 2 3 4 5 6
2 I get anxious when I go to a new restaurant. 1 2 3 4 5 6
3 I often worry about problems in my belly. 1 2 3 4 5 6
4 I have a difficult time enjoying myself because I cannot get my mind
off of discomfort in my belly.
1 2 3 4 5 6
5 I often fear that I won’t be able to have a normal bowel movement. 1 2 3 4 5 6
6 Because of fear of developing abdominal discomfort, I seldom try
new foods.
1 2 3 4 5 6
7 No matter what I eat, I will probably feel uncomfortable. 1 2 3 4 5 6
8 As soon as I feel abdominal discomfort I begin to worry and feel anxious. 1 2 3 4 5 6
9 When I enter a place I haven’t been before, one of the first things I do
is to look for a bathroom.
1 2 3 4 5 6
10 I am constantly aware of the feelings I have in my belly. 1 2 3 4 5 6
11 I often feel discomfort in my belly could be a sign of a serious illness. 1 2 3 4 5 6
12 As soon as I awake, I worry that I will have discomfort in my belly
during the day.
1 2 3 4 5 6
13 When I feel discomfort in my belly, it frightens me. 1 2 3 4 5 6
14 In stressful situations, my belly bothers me a lot. 1 2 3 4 5 6
15 I constantly think about what is happening inside my belly. 1 2 3 4 5 6
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lance [27,28]. Therefore, the ASI was used to examine the
construct validity of the VSI-J.
Procedure
The questionnaire survey was presented in the class-
room during an academic session. We explained the re-
search procedures and general purpose, and provided
both a written and verbal explanation of the intended
use of the data. In addition, we explained that persons
who did not consent to participate in the study would be
placed at no disadvantage whatsoever. We only analyzed
the data of those students who agreed to participate.
Statistical analysis
Analyses were carried out using IBM SPSS Statistics
20.0 (SPSS, Inc., Chicago, IL, USA) Descriptive statistics
are presented as means ± standard deviations (SD), along
with 95% confidence intervals. We used unpaired t-tests
to compare IBS-positive and non-IBS groups. The factor
structure of the VSI-J was confirmed by exploratory fac-
tor analysis (EFA). The internal consistency reliability of
the VSI-J was determined using Cronbach’s α. The con-
struct validity was measured using Pearson’s correlation
coefficients between the VSI-J and scores on the ASI,
HAD-ANX, HAD-DEP, and IBS-SI. The discriminant
validity of the VSI-J was measured using the partialcorrelation coefficient between the VSI-J and the IBS-SI
while controlling for HAD-ANX and ASI scores. Hier-
archical multiple regression analyses were conducted to
examine the incremental validity of the VSI-J; IBS-SI
scores were the dependent variable and the scores on
the VSI-J, ASI, and HAD-ANX were independent vari-
ables. For all tests, a p-value of .05 (two-tailed) was
regarded as the cutoff for statistical significance.
Ethics
The study protocol was approved by the Ethics Commit-
tee of Nagasaki University, which confirmed that the
study design was in accordance with the Declaration of
Helsinki; all participants provided informed consent.
Results
Demographics
Table 3 shows the demographic data for the present
study participants, and reference data for university
students obtained in a previous study [28]. The preva-
lence of IBS in the study sample was 11%; the overall
gender distribution of the sample was 59% male and
41% female. However, within the IBS-positive group,
67% were female and 33% were male. The scores were
significantly higher for the IBS-positive group than for
the non-IBS group on the VSI-J (total; t = 4.96,
p < 0.0001), the ASI (t = 2.86, p = 0.0044), and the IBS-SI
Table 3 Age, sex, and inventory scores
Variables All participants Non-IBS IBS+ Reference value [28]
(N = 349) (N = 310) (N = 39) Non-IBS IBS+
Age 18.8 ± 0.5 [18.7–18.8] 18.8 ± 0.6 [18.7–18.9] 18.8 ± 0.6 (18.6–18.8) 19 19
Sex (% male) 59 [54–64] 63 [57–68] 33 [21–49] - -
IBS + (%) 11 [8–15] - - - -
VSI 15.2 ± 13.6 [13.8–16.6] 14.0 ± 12.9 [12.5–15.4] 25.1 ± 15.3 [20.2–30.1]** 8.2 [7.2–9.2] 28.0 [22.1–33.9]
ASI 16.6 ± 9.7 [15.7–17.6] 16.1 ± 9.2 [15.0–17.1] 20.8 ± 12.4 [16.7–24.8]** 18.6 [18.5–18.7] 23.2 [19.5–26.9]
HAD-ANX 8.5 ± 4.0 [8.1–8.9] 8.4 ± 4.0 [8.0–8.9] 9.3 ± 4.5 [7.8–10.7] 6.5 [6.1–6.9] 8.5 [7.7–9.3]
HAD-DEP 7.6 ± 3.1 [7.3–7.9] 7.6 ± 3.1 [7.3–8.0] 7.5 ± 2.9 [6.5–8.4] 3.1 [2.7–3.5] 5.4 [5.0–5.8]
IBS-SI 103.8 ± 86.7 [96.1–114.0] 90.9 ± 77.3 [82.3–99.6] 206.2 ± 91.0 [176.7–225.7]** - -
Data are expressed as: mean ± standard deviation [95% confidence interval].
Abbreviations: VSI Visceral Sensitivity Index, ASI Anxiety Sensitivity Index, HAD-ANX and HAD-DEP subscales of the Hospital Anxiety and Depression Scale,
IBS-SI Irritable Bowel Syndrome Severity Index, IBS + positive diagnosis of Irritable Bowel Syndrome, Non-IBS no presence of Irritable Bowel Syndrome.
**p < 0.01 for IBS + vs. Non-IBS.
Table 2 Japanese version of the VSI
















1 2 3 4 5 6
2 新しいレストランに行くときは不安
になる
1 2 3 4 5 6




1 2 3 4 5 6
5 私は排便が正常にならないのではない
かとよく恐れている




1 2 3 4 5 6
7 たとえ何を食べても、おそらく落ち着か
ない気持ちになる
1 2 3 4 5 6
8 おなかに不快感が生じるとすぐに悩ん
だり不安になったりする
1 2 3 4 5 6
9 今まで行ったことがない場所に入っ
た時、まず最初にトイレを探す
1 2 3 4 5 6
10 私はおなかの感覚をいつも意識している 1 2 3 4 5 6
11 おなかの不快感は深刻な病気の兆候で
はないかとよく考えてしまう
1 2 3 4 5 6
12 朝起きるとすぐにその日おなかに不
快感が生じることを心配する
1 2 3 4 5 6
13 おなかに不快感が生じると怖くなる 1 2 3 4 5 6
14 ストレスの多い状況では、おなかの不快
感が増す
1 2 3 4 5 6
15 私は自分のおなかの中で何が起きて
いるかをいつも考える
1 2 3 4 5 6
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difference in the total HAD-ANX (t = 1.20, p = 0.2305)
and total HAD-DEP (t = 0.26, p = 0.7931) scores.
Factor structure
To examine the factor structure of the VSI-J, we con-
ducted an EFA (using maximum likelihood estimation
and promax rotation) without assigning the number of
factors (Table 4). There are four criteria for estimating
factor structure: [1] initial eigenvalues greater than one,
[2] shape of the scree plot, [3] interpretations of factor
structure, and [4] factor loadings greater than 0.40.
Initial eigenvalues greater than one were observed for
two factors (first factor eigenvalue = 8.18, second factor
eigenvalue = 1.17). However, the shape of the scree plot
suggested a unidimensional factor structure. Accord-
ingly, we then analyzed the factor structure by conduct-
ing exploratory analyses and assigning either one or two
factors. The results confirmed a unidimensional factor
structure. That is, a single factor accounted for 54% of
the total variance. This was consistent with findings for
the original VSI [27,28].
Reliability
To examine reliability, we calculated Cronbach’s α for all
scale measures. All measures demonstrated high internal
consistency and were therefore considered reliable (VSI-
J, α = 0.93; ASI, α = 0.88; total HAD, α = 0.73; HAD-
ANX, α = 0.66; HAD-DEP, α = 0.50; IBS-SI; α = 0.74).Table 4 Factor analysis of the Japanese version of the Viscera
Item Statement
1 I worry that whenever I eat during the day, bloating and disten
2 I get anxious when I go to a new restaurant.
3 I often worry about problems in my belly.
4 I have a difficult time enjoying myself because I cannot get my
5 I often fear that I won’t be able to have a normal bowel movem
6 Because of fear of developing abdominal discomfort, I seldom t
7 No matter what I eat, I will probably feel uncomfortable.
8 As soon as I feel abdominal discomfort I begin to worry and fe
9 When I enter a place I haven’t been before, one of the first thin
10 I am constantly aware of the feelings I have in my belly.
11 I often feel discomfort in my belly could be a sign of a serious
12 As soon as I awake, I worry that I will have discomfort in my be
13 When I feel discomfort in my belly, it frightens me.
14 In stressful situations, my belly bothers me a lot.
15 I constantly think about what is happening inside my belly.
Eigenvalue
Variance (%)
Note. While factor analysis was performed with the Japanese version of the VSI, theValidity
Construct validity
Table 5 gives Pearson’s correlation coefficients among
the VSI-J, ASI, HAD-ANX, HAD-DEP and IBS-SI. Over-
all, scores on the VSI-J were significantly correlated with
scores on the ASI (r = 0.46, p < 0.0001), HAD-ANX
(r = 0.19, p = 0.0003), and IBS-SI (r = 0.43, p < 0.0001).
However, there was no significant correlation with the
HAD-DEP (r = 0.10, p = 0.0511). For the IBS-positive
group (n = 39), there was a significant correlation between
scores on the VSI-J and scores on the ASI (r = 0.44,
p = 0.0048), HAD-ANX (r = 0.32, p = 0.0445), and IBS-SI
(r = 0.65, p < 0.0001). However, there was no significant
correlation between VSI-J and HAD-DEP scores
(r = 0.27, p = 0.0976). For the non-IBS group (n = 310),
there was a significant correlation between scores on
the VSI-J and scores on the ASI (r= 0.41, p < 0.0001),
HAD-ANX (r = 0.16, p = 0.0051), and IBS-SI (r = 0.36,
p < 0.0001). However, there was no significant correlation
between VSI-J and HAD-DEP scores (r = 0.09, p =
0.1096).
Discriminant validity
To examine the discriminant validity of the VSI-J, we
calculated the partial correlation coefficient (for the whole
sample, N = 349) between the VSI-J and IBS-SI while
controlling for scores on the HAD-ANX and ASI.
The result was a significant correlation between scores





sion in my belly will get worse. 0.53 0.61
0.42 0.52
0.72 0.78
mind off of discomfort in my belly. 0.74 0.79
ent. 0.77 0.79
ry new foods. 0.56 0.62
0.62 0.66
el anxious. 0.82 0.82
gs I do is to look for a bathroom. 0.58 0.62
0.83 0.82
illness. 0.81 0.80






original English items are given here for ease of reference.
Table 5 Correlation matrices for the construct validation
of the Japanese version of the VSI
VSI ASI HAD-ANX HAD-DEP
All (N = 349)
ASI 0.46** - - -
HAD-ANX 0.19** 0.30** - -
HAD-DEP 0.10 0.17** 0.53** -
IBS-SI 0.43** 0.24* 0.09 0.09
IBS + (N = 39)
ASI 0.44** - - -
HAD-ANX 0.32* 0.57** - -
HAD-DEP 0.27 0.47** 0.60** -
IBS-SI 0.65** 0.50** 0.30 0.24
Non-IBS (N = 310)
ASI 0.41** - - -
HAD-ANX 0.16** 0.24** - -
HAD-DEP 0.09 0.13* 0.52** -
IBS-SI 0.36** 0.14* 0.04 0.09
Abbreviations: VSI Visceral Sensitivity Index, ASI Anxiety Sensitivity Index,
HAD-ANX and HAD-DEP subscales of the Hospital Anxiety and Depression scale,
IBS-SI Irritable Bowel Syndrome Severity Index.
*p < 0.05, **p < 0.01.
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tween VSI-J and IBS-SI scores when controlling for only
the ASI (r = 0.40, p < 0.0001).
Incremental validity
To examine the ability of the VSI-J to predict GI symp-
toms, we conducted a hierarchical multiple regression
analysis (for the whole sample, N = 349) with the IBS-SI
score as the dependent variable and the VSI-J, ASI, andTable 6 Hierarchical multiple regression analysis with
IBS-SI as the dependent variable
Variable Step 1 Step 2
B SE B β t value B SE B β t value
Step 1
HAD-ANX 0.52 1.16 0.02 0.44 −0.13 1.16 0.01 0.12
ASI 2.06 0.49 0.23 4.22** 0.45 0.49 0.05 0.93
Step 2
VSI 2.78 0.33 0.43 8.23**
F value 10.51** 30.94**
Adj R2 0.052 0.205
ΔR2 0.06** 0.16**
Note. N = 349.
Abbreviations: IBS-SI Irritable Bowel Syndrome Severity Index, B regression
coefficients, SE B standard errors for regression coefficients, β standard
regression coefficient, Adj R2 adjusted multiple correlation coefficient, ΔR2
changes in the multiple squared correlation coefficient, VSI = Visceral
Sensitivity Index, ASI Anxiety Sensitivity Index, HAD-ANX subscale of the
Hospital Anxiety and Depression scale.
**p < 0.01.HAD-ANX scores as independent variables (Table 6).
For the first step, independent variables were the ASI
and HAD-ANX scores; for the second step, the independ-
ent variable was the VSI-J score. The adjusted multiple
correlation coefficient for the IBS-SI increased signifi-
cantly from the first to the second step (5.2% to 20.5%).
These findings suggest that the VSI-J contributed unique
effects to the IBS-SI.
Discussion
Our hypotheses were mainly supported by the findings
of the present study. As expected, the VSI-J exhibited a
unidimensional factor structure (Hypothesis 1). Further,
VSI-J scores were significantly and moderately correlated
with scores on the ASI, HAD-ANX, and IBS-SI (Hy-
pothesis 2); however, there was no significant correlation
between the VSI-J scores and those of the HAD-DEP. As
anticipated, when we controlled for ASI (anxiety sensitiv-
ity) and HAD-ANX (anxiety) scores, scores on the VSI-J
predicted IBS-SI (GI symptom severity; Hypothesis 3).
Our study was able to demonstrate that the VSI-J is a
sufficiently reliable measure of anxiety about GI symp-
toms. We demonstrated (using EFA) that the index has
a unidimensional factor structure similar to that of the
original VSI. Cronbach’s α was similar to that found in
previous studies [27,28] with the original VSI (α = 0.93
vs. α = 0.90–0.93, respectively), indicating that the VSI-J
also has high levels of internal consistency.
We were also able to verify the construct validity of
the VSI-J. Correlational analyses showed that scores on
the VSI-J were related to scores on measures of anxiety
sensitivity (ASI), anxiety (HAD-ANX), and the severity
of symptoms (IBS-SI). This is consistent with previous re-
search with the original VSI [27,28]. We found a signifi-
cant correlation between measures of anxiety sensitivity
and gastrointestinal specific anxiety as measured by the
VSI-J, confirming previous studies showing that individ-
uals with high trait anxiety and high anxiety sensitivity are
more likely to report feeling anxious about their gastro-
intestinal symptoms [27,28].
Generally, in IBS, a correlation is seen between depres-
sion and anxiety [11]. It has also been reported that as
GI symptoms increase in severity, psychological distress
also increases [12-14]. A previous study has reported
that scores on the VSI and the HAD-DEP are signifi-
cantly correlated in patients with a clinical diagnosis of
IBS, although this correlation was not observed in univer-
sity students with symptoms of IBS [28]. Given previously
reported findings regarding the correlation between de-
pression and anxiety in individuals diagnosed with IBS, we
expected to see at least a weak correlation between the
VSI-J scores and the scores on the depression measure
(HAD-DEP). However, we did not find such a correlation.
This may be due to the fact that, of participants in this
Saigo et al. BioPsychoSocial Medicine 2014, 8:10 Page 8 of 9
http://www.bpsmedicine.com/content/8/1/10study, those with IBS symptoms only experienced moder-
ately severe GI symptoms, as measured by the IBS-SI.
Our analyses revealed two findings important for under-
standing the relationship between anxiety and gastrointes-
tinal symptoms. The results of the partial correlation
analysis showed that the VSI-J has discriminant validity, as
shown by a significant correlation between the VSI-J and
the severity measure (IBS-SI) independent of the effects
of anxiety and anxiety sensitivity. Further, the results of
the hierarchical multiple regression analysis showed
that the VSI-J has incremental validity that uniquely af-
fects the IBS-SI. Therefore, it may be appropriate to as-
sess the symptoms of the IBS patient by treating GSA
rather than anxiety or AS. Together, these results sug-
gest two intriguing possibilities. First, AS is highly rele-
vant in cases of respiratory and cardiac sensation [35]. It
is therefore possible that the VSI-J measures fear re-
sponses to GI symptoms and GI sensations, and that it
is possible to predict the severity of IBS-SI scores. Sec-
ond, hyperactivity in the hypothalamic-pituitary-adrenal
axis and prefrontal cortex is associated with increased
levels of visceral sensitivity, which may exacerbate GI
symptoms [36]. Consequently, it is possible that GSA is
associated with symptom severity because of the direct
path of the efferent nerve originating in the brain and
projecting to the gastrointestinal tract.
It is desirable to conduct additional studies to further
confirm the reliability and validity of the VSI-J, and to
address the following points.
First, this study included only students attending a uni-
versity located in a medium-sized city on the island of
Kyushu in western Japan. Additionally, the present study
was based solely on results from a screening question-
naire; it did not include diagnosis or evaluation of symp-
tom severity by a physician. Therefore, it is not known
whether these results can be extended to clinical samples
in the general population. It will be important to replicate
our findings with a general population of patients diag-
nosed with IBS. At the same time, however, the prevalence
of IBS in this study (14%) was similar to that reported for
the general population in Japan [37]. It has also been re-
ported that individuals who had never sought treatment
for IBS symptoms had higher state anxiety compared
with healthy subjects, which matches the pattern usually
seen in IBS patients [37]. Thus, we believe sampling bias
was unlikely to have affected the conclusions of the
present study.
Additionally, at this time, the total VSI-J score does not
distinguish between minor and severe symptoms. In the
future, it will be necessary to set guidelines and cut-off
points so that the scale may be used in clinical settings.
Finally, attention to the GI symptoms of IBS patients
may be related to activity in the anterior cingulate and
prefrontal cortex [38]. It is important to further study therelationship between executive functioning and GSA, so
that eventually the VSI may be used as a measure of
brain-gut interaction.
In terms of clinical application, reductions in visceral
sensitivity (as measured by the VSI-J) are anticipated as
a possible endpoint for IBS interventions, which incorp-
orate pharmacotherapy, exercise therapy, psychother-
apy, and nutritional therapy. In recent years, the VSI has
been used in Western countries when implementing
cognitive behavioral therapy to reduce anxiety associated
with IBS symptoms [29,39,40]. Cognitive behavioral ther-
apy is used with the goal of changing individuals’ evalua-
tions of threat in situations that cause symptom anxiety
and to reduce avoidance behavior. This approach has
been shown to significantly improve GI symptoms and
GSA [29].
In conclusion, the present study examined the reliabil-
ity and validity of the newly developed VSI-J in a sample
of university students. The scale was found to be reliable
and valid in a manner consistent with the original VSI.
The VSI-J may now be used to better assess the impact
of interventions targeting the reduction of GSA in
Japanese patients with IBS. Furthermore, the results of
this study may aid in efforts to use the VSI to compare
psychological aspects of IBS patients across cultures.
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